Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

96
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
96
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.0K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

103
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
103
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

770
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
770
Drug Therapy01:28

Drug Therapy

68
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
68
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

130
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
130

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

PSO-FeatureFusion: a general framework for fusing heterogeneous features via particle swarm optimization.

Bioinformatics advances·2025
Same author

Target controllability: a feed-forward greedy algorithm in complex networks, meeting Kalman's rank condition.

Bioinformatics (Oxford, England)·2024
Same author

MiRAGE: mining relationships for advanced generative evaluation in drug repositioning.

Briefings in bioinformatics·2024
Same author

NN-RNALoc: Neural network-based model for prediction of mRNA sub-cellular localization using distance-based sub-sequence profiles.

PloS one·2023
Same author

Clinical drug response prediction from preclinical cancer cell lines by logistic matrix factorization approach.

Journal of bioinformatics and computational biology·2021
Same author

A neural network-based method for polypharmacy side effects prediction.

BMC bioinformatics·2021
Same journal

Correction to: Pathogenicity patterns in cytochrome P450 family.

Bioinformatics advances·2026
Same journal

Region-aware bridge modeling enables interpretable mesoscale representation of spatial transcriptomic tissue sections.

Bioinformatics advances·2026
Same journal

Microbiome differential abundance methodologies to detect relevant taxa associated with chemotherapy toxicity rate in colorectal cancer.

Bioinformatics advances·2026
Same journal

maldipickr dereplicates microbial MALDI-TOF spectra to facilitate multiplexed isolation.

Bioinformatics advances·2026
Same journal

RAM-MSA: an anytime memory-bounded method for exact multiple sequence alignment using path finding.

Bioinformatics advances·2026
Same journal

Interpretable machine learning for low-sample multi-omics: a case study of ferret vaccine response.

Bioinformatics advances·2026
查看所有相关文章

相关实验视频

Updated: Jul 16, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.6K

DPSP:一个多式联网深度学习框架,用于多药副作用预测.

Raziyeh Masumshah1, Changiz Eslahchi1,2

  • 1Department of Computer and Data Sciences, Faculty of Mathematical Sciences, Shahid Beheshti University, Tehran 1983969411, Iran.

Bioinformatics advances
|September 13, 2023
PubMed
概括
此摘要是机器生成的。

确定药物相互作用 (DDI) 的不良影响对于患者的安全至关重要. DPSP框架有效地利用新药特征和深度神经网络预测多药副作用,优于现有方法.

更多相关视频

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K
Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.9K

相关实验视频

Last Updated: Jul 16, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.6K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K
Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.9K

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 计算生物学 计算生物学
  • 人工智能的人工智能

背景情况:

  • 意想不到的药物相互作用 (DDI) 对健康构成重大风险.
  • 识别多药药的不良影响是人类健康的一个关键挑战.
  • 预测多种药物的副作用的计算方法已经进步.

研究的目的:

  • 介绍DPSP,这是预测多药副作用的新框架.
  • 为DDI预测开发一种深度神经网络方法.
  • 为了产生新的药物特征,以改善DDI识别.

主要方法:

  • 使用Jaccard相似性的药物信息评估和特征提取.
  • 通过结合相似之处来生成新药特征载体.
  • 应用多模式深度神经网络框架用于DDI预测.

主要成果:

  • 在基准数据集上,DPSP在GNN-DDI,MSTE和DNN等既定方法相比表现优越.
  • 该框架在各种分类指标上实现了高精度.
  • 多种药物信息的整合被证明是有效的DDI不良影响的识别.

结论:

  • DPSP框架为预测多药副作用提供了有效和高效的解决方案.
  • 利用多样化的药物信息可以提高DDI预测的准确性.
  • 该研究强调了深度学习在缓解DDI风险方面的潜力.